Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)
INR 24.21
(-0.62%)
INR 24.21
(-0.62%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -3.85 INR | -89.66% |
| 2021 | -2.03 INR | 51.55% |
| 2020 | -4.19 INR | -77.54% |
| 2019 | -2.36 INR | -76.12% |
| 2018 | -1.34 INR | -35.35% |
| 2017 | -0.99 INR | -165.56% |
| 2016 | 1.51 INR | 204.86% |
| 2015 | -1.44 INR | -500.0% |
| 2014 | 0.36 INR | -75.68% |
| 2013 | 1.48 INR | 27.59% |
| 2012 | 1.16 INR | -60.14% |
| 2011 | 2.91 INR | 400.0% |
| 2010 | -0.97 INR | 52.45% |
| 2009 | -2.04 INR | -148.78% |
| 2008 | -0.82 INR | 11.83% |
| 2007 | -0.93 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q2 | -1.14 INR | -7.55% |
| 2023 Q1 | -1.06 INR | -7.07% |
| 2022 Q2 | -0.71 INR | 38.79% |
| 2022 Q3 | -1.08 INR | -52.11% |
| 2022 Q1 | -1.16 INR | -404.35% |
| 2022 FY | - INR | -89.66% |
| 2022 Q4 | -0.99 INR | 8.33% |
| 2021 Q1 | 0.45 INR | 116.79% |
| 2021 Q2 | -2.17 INR | -582.22% |
| 2021 FY | - INR | 51.55% |
| 2021 Q3 | -0.08 INR | 96.31% |
| 2021 Q4 | -0.23 INR | -187.5% |
| 2020 Q2 | -0.90 INR | -400.0% |
| 2020 Q1 | -0.18 INR | 0.0% |
| 2020 Q4 | -2.68 INR | -509.09% |
| 2020 Q3 | -0.44 INR | 51.11% |
| 2020 FY | - INR | -77.54% |
| 2019 Q2 | -1.28 INR | -60.0% |
| 2019 Q4 | - INR | 100.0% |
| 2019 Q3 | -0.54 INR | 57.81% |
| 2019 FY | - INR | -76.12% |
| 2019 Q1 | -0.80 INR | 0.0% |
| 2018 Q1 | -0.19 INR | 0.0% |
| 2018 Q3 | 0.00 INR | 100.72% |
| 2018 FY | - INR | -35.35% |
| 2018 Q4 | - INR | -100.0% |
| 2018 Q2 | -0.58 INR | -205.26% |
| 2017 Q2 | -0.55 INR | -77.42% |
| 2017 Q4 | - INR | -100.0% |
| 2017 Q3 | 0.12 INR | 121.82% |
| 2017 Q1 | -0.31 INR | 0.0% |
| 2017 FY | - INR | -165.56% |
| 2016 FY | - INR | 204.86% |
| 2016 Q2 | 0.36 INR | 500.0% |
| 2016 Q3 | 0.33 INR | -8.33% |
| 2016 Q4 | - INR | -100.0% |
| 2016 Q1 | -0.09 INR | 0.0% |
| 2015 Q4 | - INR | 100.0% |
| 2015 Q2 | -0.57 INR | 21.92% |
| 2015 Q1 | -0.73 INR | 0.0% |
| 2015 FY | - INR | -500.0% |
| 2015 Q3 | -0.16 INR | 71.93% |
| 2014 Q4 | - INR | -100.0% |
| 2014 Q3 | 0.99 INR | 621.05% |
| 2014 Q2 | -0.19 INR | -173.08% |
| 2014 FY | - INR | -75.68% |
| 2014 Q1 | 0.26 INR | 0.0% |
| 2013 Q1 | -0.38 INR | 0.0% |
| 2013 Q2 | -0.69 INR | -81.58% |
| 2013 Q3 | 1.51 INR | 318.84% |
| 2013 Q4 | - INR | -100.0% |
| 2013 FY | - INR | 27.59% |
| 2012 Q2 | -0.58 INR | 31.76% |
| 2012 FY | - INR | -60.14% |
| 2012 Q1 | -0.85 INR | 0.0% |
| 2012 Q3 | 1.73 INR | 398.28% |
| 2012 Q4 | - INR | -100.0% |
| 2011 FY | - INR | 400.0% |
| 2011 Q3 | -0.73 INR | 0.0% |
| 2011 Q4 | - INR | 100.0% |
| 2010 FY | - INR | 52.45% |
| 2009 FY | - INR | -148.78% |
| 2009 Q4 | -0.04 INR | 0.0% |
| 2008 FY | - INR | 11.83% |
| 2008 Q4 | -0.24 INR | 0.0% |
| 2007 Q4 | -0.47 INR | 0.0% |
| 2007 FY | - INR | 0.0% |